Product Information
TRIAZOLAM 0.25 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.3501 per EA under NDC 59762371803. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
.25 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762371803
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TRIAZOLAMApproval Type
Authorized Generic (NDA)
FDA Application
NDA017892On Market Since
11/15/1982
Pharmacological Classes
Price Statistics
The NADAC for TRIAZOLAM 0.25 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 45.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3501 per EA |
|---|---|
| All-time high | $1.6632 (Mar 14, 2018) |
| All-time low | $0.2380 (Nov 20, 2024) |
| 52-week high | $0.3819 |
| 52-week low | $0.3178 |
| Median price | $1.1183 |
| Average price | $1.0042 |
| Largest weekly change | +51.7% (May 22, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TRIAZOLAM 0.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRIAZOLAM 0.25 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.3501 per EA (NDC 59762371803), effective Jun 24, 2026.
How has the price of TRIAZOLAM 0.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRIAZOLAM 0.25 MG TABLET has declined 45.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRIAZOLAM 0.25 MG TABLET?
Since Nov 28, 2013, the NADAC for TRIAZOLAM 0.25 MG TABLET has ranged from a low of $0.2380 (Nov 20, 2024) to a high of $1.6632 (Mar 14, 2018), with a median of $1.1183 per EA.
Are there cheaper alternatives to TRIAZOLAM 0.25 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as TRIAZOLAM 0.25 MG TABLET, but none are currently priced below it.
Who manufactures TRIAZOLAM 0.25 MG TABLET?
TRIAZOLAM 0.25 MG TABLET (NDC 59762371803) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification